Immune component in Non-Hodgkin's lymphomas
Închide
Articolul precedent
Articolul urmator
75 1
Ultima descărcare din IBN:
2023-12-26 18:49
SM ISO690:2012
BURUIANA, Sanda, URSAN, Mariana, ROBU, Maria, TOMACINSCHII, Victor, POPESCU, Maria, SPORÎȘ, Natalia. Immune component in Non-Hodgkin's lymphomas. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 166. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Immune component in Non-Hodgkin's lymphomas


Pag. 166-166

Buruiana Sanda, Ursan Mariana, Robu Maria, Tomacinschii Victor, Popescu Maria, Sporîș Natalia
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 22 decembrie 2023


Rezumat

Introduction. The relationship between the immune system and non-Hodgkin lymphomas (NHL) is complex. Immune complications can be assessed: before NHL, with lymphoma diagnosis, and later after treatment. Material and methods. The study included 62 NHL's patients with immune component (IC), average age 62.3±3 years, women-43 (69%), men-19 (31%), treated within the Hematology Center, Republic of Moldova (20202021). The association was analyzed according to NHL type, oncet and period of association. Results. The IC: indolent NHL 33 (58%), aggressive NHL 29 (42%) patients. Regardless of the type of NHL, immune hemolytic anemias (IHA) (31.1% and 22%), immune thrombocytopenias (IT) (12.9% and 3.8%) and immune thyroiditis (10.3% and 2.6%) prevailed. SLE independent of the NHL type was present with the same frequency (1.3%). Vasculitis, vitiligo-only in the indolent NHL, but psoriasis only in the aggressive NHL. In 82.8% of cases the association of 1 IC was appreciated, and in 17.2% multiple associations. The IC was appreciated in nodal (51.6%) and extranodal (48.4%) onset NHL, such as: spleen 23 (35.9%), thyroid gland and soft tissues (3.1% each), nasopharynx, skin, stomach and vertebra in only 1.5% each. IC developed during the NHL predominated (67.5%): IHA51.9%, IT-14.2%, autoimmune thyroiditis 1.3%. SLE, vasculitis, psoriasis, RA, vitiligo developed until NHL. Conclusions. A predominance of the immune component was demonstrated in indolent NHL with nodal, spleen onset, which developed more frequently during the disease, being predominantly manifested by IHA, IT and autoimmune thyroiditis. SLE, vasculitis, psoriasis, RA, vitiligo developed only until the diagnosis of NHL was confirmed.